TickerFacts.

A business in context

AEMD research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. DEF 14A · Proxy statement

    Report date 2026-10-01 · 0001683168-26-006844

  2. 8-K · Current report

    Report date 2026-08-28 · 0001683168-26-006815 · Items 8.01

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001683168-26-006347

  4. 8-K · Current report

    Report date 2026-08-13 · 0001683168-26-006344 · Items 2.02,7.01,9.01

  5. 8-K · Current report

    Report date 2026-07-30 · 0001683168-26-005850 · Items 3.03,5.03,9.01

  6. 8-K · Current report

    Report date 2026-07-06 · 0001683168-26-005338 · Items 1.01,8.01,9.01

  7. 4 · Ownership change

    Report date 2026-06-30 · 0001683168-26-005226

  8. 4 · Ownership change

    Report date 2026-06-30 · 0001683168-26-005225

  9. 4 · Ownership change

    Report date 2026-06-30 · 0001683168-26-005224

  10. 10-K · Annual report

    Report date 2026-03-31 · 0001683168-26-004710

  11. 8-K · Current report

    Report date 2026-06-10 · 0001683168-26-004707 · Items 2.02,7.01,9.01

  12. 8-K · Current report

    Report date 2026-06-04 · 0001683168-26-004540 · Items 8.01,9.01

  13. 4 · Ownership change

    Report date 2026-04-17 · 0001683168-26-003114

  14. 4 · Ownership change

    Report date 2026-04-17 · 0001683168-26-003113

  15. 4 · Ownership change

    Report date 2026-04-17 · 0001683168-26-003112

  16. 4 · Ownership change

    Report date 2026-04-17 · 0001683168-26-003111

  17. 4 · Ownership change

    Report date 2026-03-31 · 0001683168-26-002589

  18. 8-K · Current report

    Report date 2026-03-16 · 0001683168-26-001887 · Items 8.01

  19. 8-K · Current report

    Report date 2026-02-19 · 0001683168-26-001259 · Items 5.02,5.03,5.07,9.01

  20. 10-Q · Quarterly report

    Report date 2025-12-31 · 0001683168-26-000964

  21. 8-K · Current report

    Report date 2026-02-12 · 0001683168-26-000959 · Items 2.02,7.01,9.01

  22. 8-K · Current report

    Report date 2026-01-22 · 0001683168-26-000528 · Items 1.01,9.01

  23. DEF 14A · Proxy statement

    Report date 2026-02-19 · 0001683168-26-000364

  24. 8-K · Current report

    Report date 2025-12-02 · 0001683168-25-008953 · Items 1.01,3.03,7.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001683168-25-008271

  26. 8-K · Current report

    Report date 2025-11-12 · 0001683168-25-008257 · Items 2.02,7.01,9.01

  27. 8-K · Current report

    Report date 2025-11-06 · 0001683168-25-008001 · Items 8.01

  28. 8-K · Current report

    Report date 2025-10-22 · 0001683168-25-007719 · Items 3.01

  29. 8-K · Current report

    Report date 2025-10-16 · 0001683168-25-007586 · Items 3.03,5.03,9.01

  30. 8-K · Current report

    Report date 2025-09-12 · 0001683168-25-006917 · Items 8.01

  31. 8-K · Current report

    Report date 2025-09-04 · 0001683168-25-006788 · Items 1.01,8.01,9.01

  32. 8-K · Current report

    Report date 2025-08-21 · 0001683168-25-006360 · Items 7.01,9.01

  33. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001683168-25-006049

  34. 8-K · Current report

    Report date 2025-08-13 · 0001683168-25-006042 · Items 2.02,7.01,9.01

  35. 8-K · Current report

    Report date 2025-06-26 · 0001683168-25-004784 · Items 2.02,7.01,9.01

  36. 10-K · Annual report

    Report date 2025-03-31 · 0001683168-25-004780

  37. 8-K · Current report

    Report date 2025-06-05 · 0001683168-25-004248 · Items 8.01

  38. 8-K · Current report

    Report date 2025-05-13 · 0001683168-25-003490 · Items 5.07

  39. DEF 14A · Proxy statement

    Report date 2025-05-13 · 0001683168-25-002685

  40. 8-K · Current report

    Report date 2025-03-16 · 0001683168-25-001631 · Items 1.01,3.02,3.03,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 4 transaction rows4AExercise / conversion: 0 transaction rows0MTax / exercise payment: 3 transaction rows3FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

7 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-04-17
2026-04-21
Rossetti AngelaA · Grant / award
Acquired
Common Stock21815.02.29
2026-04-17
2026-04-21
Shah ChetanA · Grant / award
Acquired
Common Stock21815.02.29
2026-04-17
2026-04-21
Gikakis NicolasA · Grant / award
Acquired
Common Stock21815.02.29
2026-04-17
2026-04-21
BROENNIMAN EDWARD GA · Grant / award
Acquired
Common Stock21815.02.29
2026-03-31
2026-04-01
Shah ChetanF · Tax / exercise payment
Disposed
Common Stock178.02.19
2026-03-31
2026-04-01
Gikakis NicolasF · Tax / exercise payment
Disposed
Common Stock178.02.19
2026-03-31
2026-04-01
BROENNIMAN EDWARD GF · Tax / exercise payment
Disposed
Common Stock89.02.19

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000882291AETHLON MEDICAL INC

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
54930036LMXCIW3XG337
GLEIF legal name
Aethlon Medical, Inc.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2023-08-04T15:43:23Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Aethlon Medical · alias · wikidata
  • BISHOP EQUITIES INC · former SEC name · 1997-09-23 to 2000-03-13
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-03-31$0$0
2023-03-31$574.2K$646.1K
2022-03-31$294.2K$355.7K
2021-03-31$659.1K$846.4K
2020-03-31$650.2K$844.8K
2019-03-31$229.6K$304.1K
2018-03-31$149.6K$202.7K

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗